Syntocinon: Clinical Trials

17 trials of Syntocinon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 1 unknown. 17 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 117Completed 16, Unknown 1
Phase 22Completed 2

Follow Syntocinon: new trials by email Literature Review of Syntocinon trials Research Report on Syntocinon

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Oxytocin for Infants With Prader-Willi Syndrome
Oxytocin, Placebo - Prader-Willi Syndrome
Phase 1 / Phase 2CompletedUniversity of Florida152017-08-012020-03-26
Influence of Oxytocin on Resting State Neurophysiological Measures
Oxytocin, Placebo - Oxytocin
Phase 1CompletedKU Leuven562017-07-242019-08-01
Influence of Oxytocin on Neurophysiological Responses to Live Faces
Oxytocin, Placebo - Oxytocin
Phase 1 / Phase 2CompletedKU Leuven562017-07-242019-08-01
Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
Oxytocin, Placebo - Pain
Phase 1CompletedUniversity of Colorado, Boulder512017-06-212019-06-25
Oxytocin HIV Meth Study
Oxytocin, Placebo - Amphetamine Use Disorders
Phase 1CompletedUniversity of California, San Francisco482017-01-012019-03-05
Oxytocin in Spectrum Autism Disorders
Oxytocin, placebo - Autistic Disorder
Phase 1CompletedUniversity of Sao Paulo General Hospital802016-07-152019-10-28
Oxytocin, Trauma Disclosure and Intrusions
Oxytocin, Placebo - Healthy
Phase 1CompletedUniversity Hospital, Bonn702016-06-012018-02-08
Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity
Oxytocin, Lorazepam 1 mg, Placebo nasalspray - Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
Phase 1CompletedUniversity Hospital, Bonn1202016-03-032019-04-17
Intranasal Oxytocin and Enhancement of Team Cohesion
Oxytocin, Placebo comparator - Unit Cohesion
Phase 1CompletedUniversity of California, San Francisco4862015-10-012019-08-05
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
oxytocin, placebo - Alcoholism, Alcohol Related Disorders
Phase 1CompletedJohns Hopkins University272015-03-012017-12-04
Oxytocin Trial in Prader-Willi Syndrome
Intranasal oxytocin, Placebo - Prader Willi Syndrome
Phase 1CompletedUniversity of Florida242015-03-012018-04-05
Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor
oxytocin, saline - Postpartum Hemorrhage
Phase 1UnknownAin Shams University12015-01-012016-03-02
Brain Imaging of Intranasal Oxytocin Treatment in Autism
Oxytocin - Autism Spectrum Disorders
Phase 1CompletedUniversity of North Carolina, Chapel Hill332014-09-012017-04-25
Study of Wellness Behaviors as a Function of Oxytocin vs Placebo
Oxytocin, Placebo (for oxytocin), Lovingkindness Meditation - Sustained Positive Emotions, Sustained Positive Behavior Change
Phase 1CompletedUniversity of North Carolina, Chapel Hill2392013-09-012016-07-18
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
Misoprostol, Oxytocin - Post Partum Hemorrhage
Phase 1CompletedHormozgan University of Medical Sciences4002013-05-012015-03-26
The Influence of Oxytocin on the Processing of Social Contact
Placebo, Oxytocin - Healthy Male Volunteers
Phase 1CompletedUniversity Hospital, Bonn402013-03-012013-09-11
Pharmacological Approach to Improve the Outcome of Social Cognition Training
Oxytocin, Placebo, Social Cognitive Skills Training - Schizophrenia
Phase 1CompletedVA Greater Los Angeles Healthcare System272012-01-012013-03-29

Conditions studied

Autistic Disorder (2)  ·  Postpartum Hemorrhage (2)  ·  Prader-Willi Syndrome (2)  ·  Alcohol Withdrawal Delirium (1)  ·  Alcohol-Related Disorders (1)  ·  Alcoholism (1)  ·  Anxiety Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Behavior, Addictive (1)  ·  Homosexuality (1)  ·  Pain (1)  ·  Schizophrenia (1)

Sponsors

University Hospital, Bonn (3)  ·  KU Leuven (2)  ·  University of California, San Francisco (2)  ·  University of Florida (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Ain Shams University (1)  ·  Hormozgan University of Medical Sciences (1)  ·  Johns Hopkins University (1)  ·  University of Colorado, Boulder (1)  ·  University of Sao Paulo General Hospital (1)  ·  VA Greater Los Angeles Healthcare System (1)

Countries

United States (9)  ·  Germany (3)  ·  Belgium (2)  ·  Brazil (1)  ·  Egypt (1)  ·  Iran (1)

Top investigators

Kaat Alaerts, PhD (2)  ·  Allen Song, PhD (1)  ·  Barbara L Fredrickson, Ph.D. (1)  ·  Chris Stauffer, MD (1)  ·  Debora Zambori (1)  ·  Elise Weerts, Ph.D. (1)  ·  Gabriel Dichter, PhD (1)  ·  Jennifer L Miller, MD (1)  ·  Jennifer Miller, MD (1)  ·  Josh D Woolley, MD/PhD (1)  ·  Linmarie Sikich, MD (1)  ·  Minoo Rajaei, Dr (1)  ·  Stephen R Marder, MD (1)  ·  Tor D Wager, Ph. D. (1)

Results publications

PMID 24734184, PMID 30791944, PMID 34697392

NIH funding

R01NR012899 (1), U54HD079124 (1)